Mediastinal Non-Hodgkin Lymphoma — Trials

Mediastinal Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

129 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 59
Recruiting: 33
Ph III recruiting: 0
Growth YoY: —
Industry share: 24%
Top sponsor: University of Washington
Termination share: 30.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05733650	Expanded Access Program for Epcoritamab	approved for marketing	—	—	GenmabINDUSTRY	0	May 25, 2023	clinicaltrials

Data updated 22 days agoSource updated May 25, 2023source: clinicaltrials